Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors

NCT00183833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer
Colorectal Cancer

Interventions

DRUG: capecitabine, imatinib mesylate

Sponsor

University of Southern California

Collaborators

[object Object]